Podcast: The impact of synthetic biology and collaboration in pharma


This is the latest episode of the free DDW podcast. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Why synthetic biology is the next big thing for biopharma” and “Collaborative spirit helps drive innovation”.

‘Can synthetic biology save us?’ and ‘Synthetic biology can benefit us all’, are just some of the headlines this emerging scientific field has recently elicited. In the first article, Lu Rahman speaks to Dr Emily Leproust, Founder and CEO of Twist Biopharma, about the potential that synthetic biology holds within the drug discovery sector.

In the second article, Dr David Walt, a professor at Harvard Medical School who runs labs at both Brigham and Women’s Hospital and the Wyss Institute at Harvard University, shares his thoughts on the drug discovery industry and what the pandemic has taught us about lab automation. This featured in this issue’s SLAS 2022 supplement.

You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Listen here:

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free